Hybrid surgical technologies in the treatment of cystic cerebral metastases of breast cancer
pdf (Русский)

Keywords

cystic cerebral metastases
breast cancer
stereotactic radiosurgery
stereotactic aspiration

How to Cite

Subbotina, D., Sulin, K., Chizhova, K., Truscheleva, S., Kurnosov, I., Belov, I., Kartashev, A., Chirkin, V., & Gulyaev, D. (2023). Hybrid surgical technologies in the treatment of cystic cerebral metastases of breast cancer. Voprosy Onkologii, 69(3), 462–469. https://doi.org/10.37469/0507-3758-2023-69-3-462-469

Abstract

Nowadays guidelines and tactics for the treatment of solid cerebral metastases have physiological and pathogenetic grounds. But the choice of treatment for cystic cerebral metastases seems not so clear. This makes it necessary to introduce evidence-based hybrid technologies for the treatment of cystic cerebral metastases into clinical practice.

Aim. To study the possibility of treatment of cystic cerebral metastases of breast cancer using hybrid surgical technologies. We have treated 162 patients with breast metastases to the brain. The study included 15 women aged 32 to 73 years. Depending on the volume and ratio of the cystic and solid components, the following method was used: in the case when we understood that after the removal of the fluid, the volume of the solid component would be 10 cm3 or less, the first stage was stereotaxic aspiration and then radiosurgical treatment (SRS). If the expected residual volume of the solid part after the supposed aspiration of the cyst was more than 10 cm3, the tumor was resected and further SRS was performed. When the total volume of metastases was not more than 10 cm3, only stereotactic irradiation was used.

Results. The number of patients with cystic neoplasms (n=15) among all patients with cerebral metastases of breast cancer (n=162) was 9.3%. The average tumor volume before treatment was 27.5 cm3 (Q1 17.8; Q3 37.4), after treatment 8.3 cm3 (Q1 7.05; Q3 10.35). 3 (20%) patients underwent only SRS, in 8 cases (53.3%) aspiration followed by SRS was performed, 4 patients (26.7%) underwent microsurgical resection followed by SRS of the tumor. In the SRS group, the mean tumor volume was reduced from 9.3 cm3 to 3.7 cm3 (2,3;4,6 cm3), in the drainage and SRS group from 37.5 cm3 to 8.2 cm3 (1,9;12,1 cm3), in the microsurgery group followed by SRS from 21.1 cm3 to 4.9 cm3 (1,8;7,1 cm3).

Conclusion. We did not find significant differences in long-term results between the study groups. The use of hybrid surgical technologies and differentiated tactics of their choice can ensure the achievement of an acceptable quality of life in conditions of high autonomy.

https://doi.org/10.37469/0507-3758-2023-69-3-462-469
pdf (Русский)

References

Sacks P, Rahman M. Epidemiology of Brain Metastases. Neurosurg Clin N Am. 2020;31(4):481-488. doi:10.1016/j.nec.2020.06.001.

Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017;19(11):1511-21. doi:10.1093/neuonc/nox077.

Soffietti R, Abacioglu U, Baumert B, et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017;19(2):16274. doi:10.1093/neuonc/now241.

Pan HC, Sheehan J, Stroila M, et al. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg. 2005;102(Suppl):12833. doi:10.3171/jns.2005.102.s_supplement.0128.

Kim M, Cheok S, Chung LK, et al. Characteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspiration. Brain Tumor Res Treat. 2015;3(1):1-7. doi:10.14791/btrt.2015.3.1.1.

Ebinu JO, Lwu S, Monsalves E, et al. Gamma knife radiosurgery for the treatment of cystic cerebral metastases. Int J Radiat Oncol Biol Phys. 2013;85(3):667-71. doi:10.1016/j.ijrobp.2012.06.043.

Franzin A, Vimercati A, Picozzi P, et al. Stereotactic drainage and Gamma Knife radiosurgery of cystic brain metastasis. J Neurosurg. 2008;109(2):259-67. doi:10.3171/JNS/2008/109/8/0259.

Jung TY, Kim IY, Jung S, et al. Alternative treatment of stereotactic cyst aspiration and radiosurgery for cystic brain metastases. Stereotact Funct Neurosurg. 2014;92(4):234-41. doi:10.1159/000362935.

Flickinger JC, Kondziolka D, Pollock BE, et al. Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys. 1997;38(3):48590. doi:10.1016/s0360-3016(97)89481-3.

Korytko T, Radivoyevitch T, Colussi V, et al. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 2006;64(2):419-24. doi:10.1016/j.ijrobp.2005.07.980.

Bailleux C, Eberst L, Bachelot T. Treatment strategies for breast cancer brain metastases. Br J Cancer. 2021;124(1):142-155. doi:10.1038/s41416-020-01175-y.

Oshima A, Kimura T, Akabane A, et al. Optimal implantation of Ommaya reservoirs for cystic metastatic brain tumors preceding Gamma Knife radiosurgery. J Clin Neurosci. 2017;39:199-202. doi:10.1016/j.jocn.2016.12.042.

Sadik ZHA, Hanssens PEJ, Verheul JB, et al. Stereotactic cyst aspiration directly followed by Gamma Knife radiosurgery for large cystic brain metastases. Acta Neurochir (Wien). 2021;163(2):343-350. doi:10.1007/s00701-020-04273-1.

Lv J, Wu Z, Wang K, et al. Case report: Clinical and procedural implications of Ommaya reservoir implantation in cystic brain metastases followed by radiosurgery treatment. Front Surg. 2022;9:901674. doi:10.3389/fsurg.2022.901674.

Noda R, Akabane A, Kawashima M, et al. Fractionated Gamma Knife radiosurgery after cyst aspiration for large cystic brain metastases: case series and literature review. Neurosurg Rev. 2022;45(5):3457-3465. doi:10.1007/s10143-022-01835-y.

Trifiletti DM, Romano KD, Xu Z, et al. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer. J Neurooncol. 2015;124(3):421-7. doi:10.1007/s11060-015-1854-6.

Mollica L, Leli C, Puglisi S, et al. Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis. Drugs Context. 2021;10:2021-6-6. doi: 10.7573/dic.2021-6-6.

Sacco K, Muhammad A, Saleem W, et al. Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer. Oncol Lett. 2016;12(2):779-782. doi:10.3892/ol.2016.4745.

Corso G, Pravettoni G, Galimberti V, et al. Clinical implication of E-cadherin deficiency in lobular breast cancer. Breast Cancer Res Treat. 2019;173(3):751-752. doi:10.1007/s10549-018-5051-0.

Boire A, Zou Y, Shieh J, et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell. 2017;168(6):1101-1113.e13. doi:10.1016/j.cell.2017.02.025.

Alattar AA, Carroll K, Hirshman BR, et al. Cystic formation after stereotactic radiosurgery of brain metastasis. World Neurosurg. 2018;114:e719-e728. doi:10.1016/j.wneu.2018.03.066.

Redmond KJ, De Salles AAF, Fariselli L, et al. Stereotactic radiosurgery for postoperative metastatic surgical cavities: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines. Int J Radiat Oncol Biol Phys. 2021;111(1):68-80. doi:10.1016/j.ijrobp.2021.04.016.

Park K, Bae GH, Kim WK, et al. Radiotherapy for brain metastasis and long-term survival. Sci Rep. 2021;11(1):8046. doi:10.1038/s41598-021-87357-x.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2023